Boeing Stock Jumps After Rare Double Upgrade from Sell to Buy
Stronger deliveries and analyst support are in focus.
Already have an account? Sign in.
Stronger deliveries and analyst support are in focus.
The non-binding bid values the rare obesity drugmaker at up to $134 a share.
Arm reported record Q2 revenue of $1.44 billion, up 27% year over year, driven by strong licensing growth and rising AI-related demand.
Record third-quarter results show AppLovin revenue up 55% to $2.18B and net income up 72% to $1.44B, alongside raised fourth-quarter guidance.
Be the first to know when deals break, stocks move, or biotech headlines hit.